SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-14-047728
Filing Date
2014-02-12
Accepted
2014-02-12 14:16:00
Documents
2
Group Members
ANSBERT GADICKEKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT II LLCMPM ASSET MANAGEMENT II, L.P.MPM ASSET MANAGEMENT INVESTORS 2002 BVII LLCMPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KGMPM BIOVENTURES II, L.P.NICHOLAS GALAKATOS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d677559dsc13ga.htm SC 13G/A 196460
2 EX-A d677559dex99a.htm EX-99.A 17941
  Complete submission text file 0001193125-14-047728.txt   216342
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 6174259200
MPM BIOVENTURES II QP LP (Filed by) CIK: 0001264830 (see all company filings)

IRS No.: 043523699 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 650 E. KENDALL STREET CAMBRIDGE MA 02142
Business Address 650 E. KENDALL STREET CAMBRIDGE MA 02142 6172995000
AVEO PHARMACEUTICALS INC (Subject) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85745 | Film No.: 14599269
SIC: 2834 Pharmaceutical Preparations